Re: Karim Fizazi, Charles G. Drake, Tomasz M. Beer, et al. Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.07.032
Ludmir, Ethan B., McCaw, Zachary R., Wei, Lee-JenJournal:
European Urology
DOI:
10.1016/j.eururo.2020.09.049
Date:
October, 2020
File:
PDF, 366 KB
2020